Institutional Strategies Main

INTERNATIONAL GROWTH

Strategy Objective

A non-U.S. all-cap equity strategy that seeks to invest in the common stocks of growth companies based outside the United States.

Attributes
  • Rigorous Capital Structure Analysis
  • Holistic Approach Tying Macro Perspectives to Fundamental Analysis
  • High Active Share
  • Conviction in Growth Companies and Style Purity
  • Team-Managed
Benefits
  • Diversification from Market Capitalization Weighted Indices
  • Leveraging the Experience of over 50 Investment Professionals

Sector Weightings

AS OF 31/3/13
% of Assets MSCI ACWI ex-US Growth Index Under/Overweight %
Information Technology 32.8% 8.6%
Health Care 16.7 9.4
Consumer Staples 12.8 19.1
Energy 9.8 6.2
Consumer Discretionary 8.6 12.7
Materials 6.6 11.6
Financials 6.1 14.9
Industrials 5.6 12.7
Telecommunication Services 1.0 3.3
Utilities 0.0 1.5
 

Representative Portfolio Ten Largest Holdings

AS OF 31/3/13
Company Country Sector %
Accenture, PLC - Class A Ireland Information Technology 5.0
SAP, AG Germany Information Technology 4.9
Novo Nordisk, A/S - Class B Denmark Health Care 4.4
Swatch Group, AG Switzerland Consumer Discretionary 4.2
Taiwan Semiconductor Manufacturing Company, Ltd. Taiwan Information Technology 4.2
Companhia de Bebidas das Americas Brazil Consumer Staples 3.7
Samsung Electronics Company, Ltd. South Korea Information Technology 2.7
Covidien, PLC Ireland Health Care 2.6
Anheuser-Busch InBev, NV Belgium Consumer Staples 2.4
Tata Consultancy Services, Ltd. India Information Technology 2.3

Characteristics

AS OF 31/3/13
  Calamos Portfolio MSCI ACWI ex-US Growth Index
Assets in Strategy $1.7 billion N/A
# of Holdings 77 1,025
Portfolio Turnover % (5-Year) 69.6% N/A
Median Market Cap ($bil) $15.5 $7.0
Weighted Average Market Cap ($bil) $51.6 $50.8
ROIC % 23.2% 15.6%
Debt/Capital % 17.1% 36.4%
PEG Ratio (1 year forward) 1.4x 1.5x

Largest Country Weightings

AS OF 31/3/13
Representative Portfolio MSCI ACWI ex-US Growth Index
Switzerland 11.5% 9.3%
United Kingdom 9.2% 14.3%
Ireland 9.1% 0.7%
Taiwan 8.4% 2.6%
Germany 7.0% 6.0%
India 6.1% 1.5%
Norway 5.2% 0.2%
Canada 4.9% 7.0%
Denmark 4.4% 1.3%
South Korea 4.3% 3.5%

Global Summary

AS OF 31/3/13
Representative Portfolio MSCI ACWI ex-US Growth Index
Developed Markets 72.2% 77.9%
Emerging Markets 27.8% 22.1%

Composite Summary

AS OF 31/3/13
Period Ending Composite Assets (in Millions) Total Assets (in Millions) % Of Total Assets Managed # Of Clients Average Acct. Size (in Millions)
12/31/2012 1,660 30,580 5.4% 6 277
12/31/2011 794 32,777 2.4% 2 397
12/31/2010 332 35,414 0.9% 1 332
12/31/2009 241 32,144 0.7% 1 241
12/31/2008 180 23,522 0.8% 1 180
12/31/2007 540 46,208 1.2% 1 540
12/31/2006 332 44,725 0.7% 1 332
12/31/2005 158 43,805 0.4% 1 158

44604C

As of 31/3/13

Annualized Total Returns

5.29%10.49%5.04%10.43%
4.36%9.42%4.03%9.36%
9.46%5.81%0.13%6.24%

As of 31/3/13

Calendar Year Returns




As of 31/3/13

Rolling 3-Year Returns

3 Years Ended




44604B

Risk/Reward Since Inception

AS OF 31/3/13
  Calamos International Growth Composite MSCI ACWI ex-US Growth Index (USD)
Alpha 4.00% N/A
Beta 1.03 1.00
Standard Deviation 21.28% 19.92%
Upside Semivariance 20.24% 15.90%
Downside Semivariance 18.56% 17.64%
Sharpe Ratio 0.41 0.20
Information Ratio 0.73 N/A

Since Inception Up/Down Capture Vs. MSCI ACWI ex-US Growth Index

AS OF 31/3/13

44604B

Strategy Vehicles

Separately Managed Accounts Minimum: $25 million
Commingled Pool $1 million
Available for both qualified and non-qualified plans.
Institutional Mutual Fund (CIGIX) Minimum $1 million

34604E

Fact Sheet The International Growth Strategy fact sheet provides a snap shot of the investment team, the investment strategy, performance, composition, ratings and returns.
Performance Review
A discussion of the Calamos International Growth Strategy’s performance versus a benchmark, positioning, related market commentary, and outlook.
Finding Growth Opportunities in Non-U.S. Equity Markets A discussion of the Calamos International Growth strategy which has historically provided a focus on high-quality growth companies; diversification across sectors and non-U.S. markets; and strong excess returns versus the MSCI ACWI ex-US Growth Index.
Equity Valuation Process A review of Calamos Investments’ research process for determining a company’s business valuation and how Calamos research uncovers the economic profits of a company and how our research determines the quality of the cash flows, the return on capital, and finally, the equity’s valuation.
Investment Team View the Growth/Convertible Team biographies

Strategy Details




As of 31/3/13
Inception Date:
01/4/05
Strategy Assets*:
$1.7 B
Benchmark:
MSCI ACWI ex-US Growth Index

Resources

* Strategy Assets includes assets under management as well as assets for which the company provides model portfolio design and oversight.